World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
27821
World Ranking
1310
National Ranking
677

Medicine

D-Index
85
Citations
27831
World Ranking
14557
National Ranking
7369

Luciano Adorini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luciano Adorini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 248 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Luciano Adorini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luciano Adorini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Luciano Adorini is affiliated with Intercept Pharmaceuticals in the United States and has made significant contributions to the field of medicine, particularly focusing on hepatology and related subfields. Their work encompasses aspects of oncology, surgery, epidemiology, molecular biology, and multiple areas within liver disease research.

Their research covers specific areas such as drug transport and resistance mechanisms, liver disease diagnosis and treatment, immunity related to liver diseases, liver disease and transplantation, Helicobacter pylori-associated gastroenterology, organ transplantation techniques and outcomes, and pediatric hepatobiliary diseases and treatments.

Adorini has published extensively in prominent journals, with frequent publication venues including:

  • Journal of Hepatology
  • American Journal of Physiology-Gastrointestinal and Liver Physiology
  • Digestive and Liver Disease
  • Gastroenterology
  • Liver International

Recent notable papers authored or coauthored by Luciano Adorini comprise:

  • FXR agonists in NASH treatment, 2023, Journal of Hepatology
  • Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model, 2020, Scientific Reports
  • The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice, 2022, Journal of Biological Chemistry
  • An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations, 2023, Hepatology
  • FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH, 2023, Liver International

Throughout their research career, Adorini has collaborated frequently with several coauthors, including:

  • G. Palladini
  • Andrea Ferrigno
  • Mariapia Vairetti
  • Laura Giuseppina Di Pasqua
  • Marta Cagna

The main disciplines of study covered by Luciano Adorini's publications are highly concentrated in medicine, with a total of 72 publications, and subfields such as:

  • Oncology (19 publications)
  • Surgery (16 publications)
  • Epidemiology (15 publications)
  • Hepatology (13 publications)
  • Molecular Biology (7 publications)

Luciano Adorini's work especially addresses liver diseases with a focus on nonalcoholic steatohepatitis (NASH) and the role of farnesoid X receptor (FXR) agonists, investigating both molecular mechanisms and therapeutic interventions.

Best Publications

  • 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation

    Giuseppe Penna;Luciano Adorini

  • THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses

    Maurice K. Gately;Louis M. Renzetti;Jeanne Magram;Alvin S. Stern

  • Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures

    Claudia Winzler;Patrizia Rovere;Maria Rescigno;Francesca Granucci

  • Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance

    Silvia Gregori;Mara Casorati;Susana Amuchastegui;Simona Smiroldo

  • The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents

    Chantal Mathieu;Luciano Adorini

  • A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice

    Silvia Gregori;Nadia Giarratana;Simona Smiroldo;Milan Uskokovic

  • Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration

    G. Condorelli;U. Borello;L. De Angelis;M. Latronico

  • Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.

    S Trembleau;G Penna;E Bosi;A Mortara

  • Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes.

    Francesca Aloisi;Francesco Ria;Luciano Adorini

  • Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.

    Giuseppe Penna;Andrea Roncari;Susana Amuchastegui;Kenn C. Daniel

  • 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells.

    Giuseppe Penna;Susana Amuchastegui;Nadia Giarratana;Kenn C. Daniel

  • The role of IL-12 in the induction of organ-specific autoimmune diseases

    Sylvie Trembleau;Luciano Adorini;Tieno Germann;Maurice K. Gately

  • Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells

    Giuseppe Penna;Silvano Sozzani;Luciano Adorini

  • Seminal Plasma Cytokines and Chemokines in Prostate Inflammation: Interleukin 8 as a Predictive Biomarker in Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Benign Prostatic Hyperplasia

    Giuseppe Penna;Nicola Mondaini;Susana Amuchastegui;Selene Degli Innocenti

  • The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I IFNs

    Lars Rogge;Daniele D’Ambrosio;Mauro Biffi;Giuseppe Penna

  • The control of T cell responses by dendritic cell subsets.

    Steven D Reid;Giuseppe Penna;Luciano Adorini

  • Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice.

    Eleni Beli;Yuanqing Yan;Leni Moldovan;Cristiano P. Vieira

  • Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).

    Aldo Del Maschio;Ada De Luigi;Ines Martin-Padura;Manfred Brockhaus

  • Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3

    Frank Mattner;Simona Smiroldo;Francesca Galbiati;Marc Muller

  • Microglia Are More Efficient Than Astrocytes in Antigen Processing and in Th1 But Not Th2 Cell Activation

    Francesca Aloisi;Francesco Ria;Giuseppe Penna;Luciano Adorini

  • Interleukin 12 Administration Induces T Helper Type 1 Cells and Accelerates Autoimmune Diabetes in NOD Mice By Sylvie Trembleau,* Giuseppe Penna,* Emanuele Bosi,~

    Anna Mortara;Maurice K. Gately;Luciano Adorini

Frequent Co-Authors

Giuseppe Penna
Giuseppe Penna European Institute of Oncology
Milan R. Uskokovic
Milan R. Uskokovic Roche (Switzerland)
Silvia Gregori
Silvia Gregori Vita-Salute San Raffaele University
Jean-Charles Guéry
Jean-Charles Guéry Federal University of Toulouse Midi-Pyrénées
Mario Maggi
Mario Maggi University of Florence
Linda Vignozzi
Linda Vignozzi University of Florence
Ettore Appella
Ettore Appella National Institutes of Health
Gianvito Martino
Gianvito Martino Vita-Salute San Raffaele University
Francesca Aloisi
Francesca Aloisi Istituto Superiore di Sanità
Pietro Luigi Poliani
Pietro Luigi Poliani University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology opens doors to diverse careers in healthcare and research. For those interested in clinical roles, accelerated nursing programs are a popular option. Many students benefit from pursuing an accelerated NP program, which fast-tracks the path to becoming a Nurse Practitioner, combining advanced nursing skills with immunology knowledge.

Individuals new to the field can start with foundational education through online RN programs for non nurses in Florida. These programs provide a flexible route to obtain registered nurse credentials online, perfectly suited for career changers interested in immunological practices.

Additionally, many students seek programs with more accessible entry points. Those searching for simpler admission criteria might consider absn programs with high acceptance rates, which offer faster routes to a Bachelor of Science in Nursing while maintaining quality education that complements immunology study.

For a quicker pathway into patient care roles, lpn programs easy to get into provide practical training and certification. Licensed Practical Nurses often collaborate closely with immunology practitioners, making this an excellent stepping stone for related career advancement.

Best Scientists Citing Luciano Adorini

Trending Scientists

Recently Published Articles